Recap: Kiniksa Pharmaceuticals Q1 Earnings

 

Kiniksa Pharmaceuticals KNSA reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Kiniksa Pharmaceuticals beat estimated earnings by 12.2%, reporting an EPS of $-0.36 versus an estimate of $-0.41.

Revenue was up $32.19 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11 which was followed by a 5.93% drop in the share price the next day.

Here's a look at Kiniksa Pharmaceuticals's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.42 -0.65 -0.79 -0.80
EPS Actual -0.53 -0.44 -0.61 -0.72
Revenue Estimate 20.72M 10.18M 3.97M 3.72M
Revenue Actual 18.75M 12.10M 7.70M 0

To track all earnings releases for Kiniksa Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!